|"We are on the threshold of change in the industry and biotechnology is driving global transformation... The Karnataka government is in the process of setting up 12 finishing schools across the state that will allow the students to gain hands-on experience, making them industry-ready. These finishing schools will be beneficial for the students as well as the industry."
Mr B M Vijay Shankar, additional managing director of KBITS and chief guest of the event
|Tips on entrepreneurship
Dr Satya Dash, COO of the Association of Biotechnology Led Enterprises (ABLE), spoke on how ABLE was associated with biotech graduates. “ABLE provides a platform for catalyzing the growth of biotech by helping new start-ups connect to sources of venture capital. The BEST program allows budding entrepreneurs to interact with leaders from the industry and gain an understanding about the process involved in transforming an idea into a product. In the biotech field, the sky is limit, but students should make ample use of the information available to them, to move ahead,” he said.
|Market needs on mind
Dr V N Balaji, CSO, Jubilant Biosys, sketched out the entire drug discovery process for the students. “One of the most essential steps involving target discovery was very promising as its complexity provided ample scope for identifying new validated targets. A thorough knowledge of medicinal and organic chemistry along with an understanding of bioinformatics is essential for a career in drug discovery,” he said. Pointing out the disconnect between student knowledge and market requirements, he added, “Collaboration with academic institutions is necessary to help design and incorporate elements required by the industry into the syllabus.”
|Interest is key
While discussing the opportunities before students, Dr Gopal Vaidyanathan, general manager, Applications, Waters India, had a word of advice for them. “Students should recognize their interests and keep them in mind while making a decision,” he said. “They should talk to people and understand the various opportunities available.” He said setting goals was very important, “but the refinement of goals is a natural progression”. He explained how scientists and engineers work together to produce a finished product and how there were ample opportunities in sales and marketing in this segment.
|Going back to basics
Ms Aindrila Dasgupta, senior manager-R&D, Novozymes, gave insights into the growing field of enzyme technology and how it affected our lives. “The synthesis of enzymes involves people from all backgrounds, including microbiology, protein engineering and bioinformatics, which provides plenty of scope to students. A strong command over basics is an absolute necessity and an ability to correlate the theory learned in classrooms and its practical applications is a must.”
|Insights on clinical research
Dr Saral Thangam, managing director of Norwich Clinical Services, explained the intricacies involved in clinical research. She explained the importance of clinical research as it was the means by which new medicines were introduced into the market while also elucidating the different job roles in a CRO. “In clinical research, pharmacovigilance is a rapidly growing sector with ample job opportunities. It extends beyond the production of the drug, with continuous research to check the long term efficacy of the drug,” she said.
|The HR point of view
Mr Ravi Dasgupta, head of human resource, Biocon Group, helped students understand what the industry was looking for in biotechnology graduates. He stressed on internships and said students should make the most of such opportunities as the experience enables them to ease into the work environment of the industry without too many problems. He also briefed students about the importance of soft skills during the recruitment process. “Communication and inter-personal skills go a long way in helping one survive in the industry and should be taught to students. Students should be able to work in a team alongside other individuals,” he said.